SCHEMBL257146

SCHEMBL257146

Nc1ccc(Oc2ccc(N(CCN(c3ccccc3)c3ccc(Oc4ccc(N)cc4)cc3)c3ccccc3)cc2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.61
ALDH1A1 P00352 6/20 0.52
TDP1 Q9NUW8 3/20 0.52
CYP3A4 P08684 2/20 0.52
TSHR P16473 1/20 0.52
MAPT P10636 5/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
RAB9A P51151 2/20 0.50
L3MBTL1 Q9Y468 2/20 0.50
NPC1 O15118 1/20 0.50
NLRP3 Q96P20 1/20 0.50
KDM4E B2RXH2 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
NR3C1 P04150 1/20 0.48
SMN1; SMN2 Q16637 4/20 0.47
GAA P10253 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28807714 0.90 MAOA (0.53) MAOAALDH1A1TDP1CYP3A4TSHR
SCHEMBL18979892 0.88 CYP3A4 (0.62) MAOAALDH1A1TDP1CYP3A4TSHR
SCHEMBL13915187 0.82 ALDH1A1 (0.75) MAOAALDH1A1TDP1CYP3A4TSHR
SCHEMBL15295353 0.82 ALDH1A1 (0.75) MAOAALDH1A1TDP1CYP3A4TSHR
SCHEMBL21391492 0.81 NR3C1 (0.48) ALDH1A1TDP1MAPTCYP2C19NR3C1
SCHEMBL13926341 0.79 MAOA (0.75) MAOAALDH1A1TDP1CYP3A4TSHR
SCHEMBL18979908 0.79 CYP3A4 (0.56) MAOAALDH1A1TDP1CYP3A4TSHR
SCHEMBL257147 0.78 ALDH1A1 (0.67) MAOAALDH1A1TDP1CYP3A4TSHR
Diphenylether SCHEMBL28089995 0.77 MAOA (1.00) MAOAALDH1A1TDP1CYP3A4TSHR
SCHEMBL554324 0.77 MAOA (1.00) MAOAALDH1A1TDP1CYP3A4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3159737-B1 LIQUID CRYSTAL DISPLAY ELEMENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL ALIGNMENT TREATMENT AGENT NISSAN CHEMICAL CORP (JP) 2021-05-26 EP disclosed
WO-2018043326-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学工業株式会社 2018-03-08 WO disclosed
WO-2018043325-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME 日産化学工業株式会社 2018-03-08 WO disclosed
WO-2017170681-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学工業株式会社 2017-10-05 WO disclosed
US-20170184923-A1 LIQUID CRYSTAL DISPLAY ELEMENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL ALIGNMENT TREATMENT AGENT NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-06-29 US disclosed
US-20170184923-A1 LIQUID CRYSTAL DISPLAY ELEMENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL ALIGNMENT TREATMENT AGENT NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2017-06-29 US disclosed
US-9447240-B2 Polyimide precursor modified with dicarboxylic acid anhydride, imidized polyimide and liquid crystal aligning agent using it NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-09-20 US disclosed
US-9447240-B2 Polyimide precursor modified with dicarboxylic acid anhydride, imidized polyimide and liquid crystal aligning agent using it NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2016-09-20 US disclosed
WO-2016076348-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学工業株式会社 2016-05-19 WO disclosed
WO-2015022980-A1 LIQUID CRYSTAL DISPLAY ELEMENT 日産化学工業株式会社 (JP) 2015-02-19 WO disclosed
WO-2014119682-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学工業株式会社 (JP) 2014-08-07 WO disclosed
WO-2014104015-A1 NOVEL DIAMINE, POLYMER, LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME 日産化学工業株式会社 (JP) 2014-07-03 WO disclosed
US-20140066590-A1 POLYIMIDE PRECURSOR MODIFIED WITH DICARBOXYLIC ACID ANHYDRIDE, IMIDIZED POLYIMIDE AND LIQUID CRYSTAL ALIGNING AGENT USING IT NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2014-03-06 US disclosed
WO-2013115228-A1 NOVEL DIAMINE, POLYMER, LIQUID CRYSTAL ALIGNMENT AGENT, AND LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME 日産化学工業株式会社 (JP) 2013-08-08 WO disclosed
WO-2013094618-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, LIQUID CRYSTAL DISPLAY ELEMENT USING SAME, AND COMPOUND 日産化学工業株式会社 (JP) 2013-06-27 WO disclosed
WO-2013081064-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME 日産化学工業株式会社 (JP) 2013-06-06 WO disclosed
WO-2012161329-A1 LIQUID CRYSTAL ALIGNING AGENT AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME 日産化学工業株式会社 (JP) 2012-11-29 WO disclosed
WO-2012029763-A1 DIAMINE, POLYIMIDE PRECURSOR, POLYIMIDE, LIQUID-CRYSTAL ALIGNMENT MATERIAL, LIQUID-CRYSTAL ALIGNMENT FILM, AND LIQUID-CRYSTAL DISPLAY ELEMENT 日産化学工業株式会社 (JP) 2012-03-08 WO disclosed
WO-2012005266-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME 日産化学工業株式会社 (JP) 2012-01-12 WO disclosed
EP-1403325-B1 LIQUID CRYSTAL ORIENTATION AGENTS AND LIQUID CRYSTAL DISPLAY DEVICE WITH THE USE THEREOF NISSAN CHEMICAL IND LTD (JP) 2007-01-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140066590-A1 POLYIMIDE PRECURSOR MODIFIED WITH DICARBOXYLIC ACID ANHYDRIDE, IMIDIZED POLYIMIDE AND LIQUID CRYSTAL ALIGNING AGENT USING IT CCDC22, RCC1, MACF1 MAOA 4410/4885ALDH1A1 2247/4885TDP1 2402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.